ClinicalTrials.Veeva

Menu

Post Radiotherapy MRI Based AI System to Predict Radiation Proctitis for Pelvic Cancers (MRI-RP-2021)

Sun Yat-sen University logo

Sun Yat-sen University

Status

Not yet enrolling

Conditions

Pelvic Cancer

Treatments

Diagnostic Test: Artificial Intelligence

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

In this study, investigators utilize a Artificial Intelligence (AI) supportive system to predict radiation proctitis for patients with pelvic cancers underwent radiotherapy. By the system, whether the participants achieve the radiation proctitis will be identified based on the radiomics features extracted from the post radiotherapy Magnetic Resonance Imaging (MRI) . The predictive power to discriminate the radiation proctitis individuals from non-radiation proctitis patients, will be validated in this multicenter, prospective clinical study.

Full description

This is a multicenter, prospective, observational clinical study for seeking out a better way to predict the radiation proctitis in patients with pelvic cancers based on the post-radiotherapy Magnetic Resonance Imaging (MRI) data. Patients who have been pathologically diagnosed as pelvic cancers will be enrolled from the Sixth Affiliated Hospital of Sun Yat-sen University, Sir Run Run Shaw Hospital and the Third Affiliated Hospital of Kunming Medical College. Patients with pelvic cancers who received radiotherapy will be enrolled and their post-radiotherapy MRI images will be used to predict their radiation proctitis or not. The clinical symptoms, endoscopic findings, imaging and histopathology as a standard. The predictive efficacy will be tested in this multicenter, prospective clinical study.

Enrollment

400 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • pathologically diagnosed as pelvic tumours
  • intending to receive or undergoing radiotherapy
  • MRI (high-solution T2-weighted imaging, contrast-enhanced T1-weighted imaging, and diffusion-weighted imaging are required) examination is completed after radiotherapy

Exclusion criteria

  • insufficient imaging quality of MRI (e.g., lack of sequence, motion artifacts)
  • incomplete radiotherapy

Trial contacts and locations

4

Loading...

Central trial contact

Xinjuan Fan, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems